( भारतीय चिकित्सा अनुसंधान परिषद् )

७३,'जी'-ब्लॉक एम.आय.डी.सी. भोसरी, पुना - ४११०२६, महाराष्ट्र, भारत.

  Current Openings at NARI                        NARI GST Number
Publications 2017
  • Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
    Singh HO, Lata S, Angadi M, Bapat S, Pawar J, Nema V, Ghate MV, Sahay S, Gangakhedkar RR.
    Pharmacogenomics J. 2017 Jan; 17(1):53-60
  • Feasibility of Using Two versus Three Rapid Tests for HIV Diagnosis in India: Analysis of Public Health Program Data
    Kale V, Beri A, Thakar M, Dar VS, Bembalkar S, Goel N, Risbud A, Paranjape R
    World J AIDS 2017 Jan; 7 (1):16-22.
  • Determination of pesticide and phthalate residues in tea by QuEChERS method and their fate in processing.
    Yadav S, Rai S, Srivastava AK, Panchal S, Patel DK, Sharma VP, Jain S, Srivastava LP
    Environ Sci Pollut Res Int. 2017 Jan;24(3):3074-3083. doi: 10.1007/s11356-016-7673-2.
  • Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein.
    Kulkarni A, Kurle S, Shete A, Ghate M, Godbole S, Madhavi V, Kent SJ, Paranjape R, Thakar M.
    Front Immunol. 2017 Jan 19;8:5. doi: 10.3389/fimmu.2017.00005. eCollection 2017.
  • Human Immunodeficiency Virus-1 Impairs IFN-Alpha Production Induced by TLR-7 Agonist in Plasmacytoid Dendritic Cells.
    Dhamanage A, Thakar M, Paranjape R
    Viral Immunol. 2017 Jan/Feb;30(1):28-34.
  • Low Immune Activation Is Associated with Higher Frequencies of Central Memory T Cell Subset in a Cohort of Indian Long-Term Nonprogressors.
    Saxena V, Bichare S, Singh D, Ghate M, Godbole S, Kulkarni S, Gangakhedkar R, Paranjape R, Thakar M
    AIDS Res Hum Retroviruses. 2017 Feb;33(2):121-125. doi: 10.1089/AID.2016.0210.
  • Evaluation of the Quality Indicators in Laboratories at National AIDS Research Institute, Pune, India
    Kulkarni S, Kale S, Ghodke U, Risbud A, Kulkarni S.
    Natl J Comm Med. 2017; 8(2): 47-51.
  • Development of IFN-γ secretory ELISPOT based assay for screening of ADCC responses.
    Shete A, Suryawanshi P, Chavan C, Kulkarni A, Godbole S, Ghate M, Thakar M.
    J Immunol Methods. 2017 Feb; 441:49-55.
  • Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.
    Mane A, Sahasrabuddhe VV, Nirmalkar A, Risbud AR, Sahay S, Bhosale RA, Vermund SH, Mehendale SM.
    J Clin Virol. 2017 Mar; 88:26-32.
  • Discordant HIV DNA PCR results among infants diagnosed with HIV infection and initiated on ART: a case series.
    Jagtap DD, Gawde NC, Kamble SV, Sharma AP, Paranjape RS.
    Int J STD AIDS. 2017 Mar; 28(4):415-417. doi: 10.1177/0956462416669852
  • Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice.
    Kulkarni A, Bhat R, Malik M, Sane S, Kothari S, Vaidya S, Chowdhary A, Deshmukh RA.
    Iran J Med Sci. 2017 Mar;42(2):152-160.
  • Domestic Violence against women in India: a systematic review of a decade of quantitative studies
    Kalokhe AS, del Rio C, Dunkle KL,Stephenson R, Metheny N, Paranjape A, Sahay S.
    Glob Public Health. 2017 Apr; 12(4):498-513.
  • Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains.
    Suryawanshi R, Jadhav S, Makwana N, Desai D, Chaturbhuj D, Sonawani A, Idicula-Thomas S, Murugesan V, Katti SB, Tripathy S, Paranjape R, Kulkarni S.
    Bioorg Chem. 2017 Apr; 71:211-218. doi: 10.1016/j.bioorg.2017.02.007.
  • Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Shaikh N, Gupte A, Dharmshale S, Pokkali S, Thakar M, Upadhye VJ, Ordonez AA, Kinikar A, Gupte N, Mave V, Kagal A, Gupta A, Lalvani A, Paranjpe R, Bharadwaj R, Jain SK.
    Int J Tuberc Lung Dis. 2017 Apr 1;21(4):412-419. doi: 10.5588/ijtld.16.0428.
  • Virologic outcomes in early antiretroviral treatment: HPTN 052
    Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, Godbole SV, Chotirosniramit N, Santos BR, Shava E, Mills LA, Panchia R, Mwelase N, Mayer KH, Chen YQ, Cohen MS, Fogel JM.
    HIV Clin Trials. 2017 May;18(3):100-109. doi: 10.1080/15284336.2017.1311056.
  • Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.
    Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Melo MG, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Chen YQ, Cohen MS, Eshleman SH, Fogel JM.
    PLoS One. 2017 May 8;12(5):e0177281. doi: 10.1371/journal.pone.0177281.
  • CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.
    Singh H, Lata S, Nema V, Samani D, Ghate M, Gangakhedkar RR
    APMIS. 2017 Jun; 125(6):523-535. doi: 10.1111/apm.12683.
  • West Nile Virus.
    Saxena V, Bolling BG, Wang T.
    Clin Lab Med. 2017 Jun;37(2):243-252. doi: 10.1016/j.cll.2017.01.001.
  • Association of gender disadvantage factors and gender preference with antenatal depression in women: a cross-sectional study from rural Maharashtra.
    Shidhaye P, Shidhaye R, Phalke V.
    Soc Psychiatry Psychiatr Epidemiol. 2017 Jun;52(6):737-748.
  • Acetone and methanol fruit extracts of Terminalia paniculata inhibit HIV-1 infection in vitro.
    Durge A, Jadaun P, Wadhwani A, Chinchansure AA, Said M, Thulasiram HV, Joshi SP, Kulkarni SS.
    Nat Prod Res. 2017 Jun;31(12):1468-1471. doi: 10.1080/14786419.2016.1258561
  • Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study.
    Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Christian P, Semba RD, Campbell TB, Gupta A; NWCS319 and ACTG 5175 study team.
    J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):e71-e79.
  • Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, Kent SJ; ENCORE1 Study Group.
    J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):345-353.
  • GeneXpert HIV-1 quant assay, a new tool for scale up of viral load monitoring in the success of ART programme in India
    Kulkarni S, Jadhav S, Khopkar P, Sane S, Londhe R, Chimanpure V, Dhilpe V, Ghate M, Yelagate R, Panchal N, Rahane G, Kadam D, Gaikwad N, Rewari B, Gangakhedkar R.
    BMC Infect Dis. 2017 Jul 21;17(1):506.
  • CD1d-Restricted Natural Killer T Cells Are Preserved in Indian Long-Term Nonprogressors.
    Singh D, Ghate M, Godbole S, Kulkarni S, Thakar M
    J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):e104-e112.
  • PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
    Gupta A, Pal SK, Pandey D, Fakir NA, Rathod S, Sinha D, SivaKumar S, Sinha P, Periera M, Balgam S, Sekar G, UmaDevi KR, Anupurba S, Nema V.
    Ann Clin Microbiol Antimicrob. 2017 Aug 18;16(1):56.
  • Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J, Nema V, Dhas Y, Mishra N.
    Biochimie. 2017 Aug;139:9-19.
  • Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study.
    Karade SK, Kulkarni SS, Ghate MV, Patil AA, Londhe R, Salvi SP, Kadam DB, Joshi RK, Rewari BB, Gangakhedkar RR.
    PLoS One. 2017 Aug 1;12(8):e0181889.
  • Host Pharmacogenomics: to be Remembered while Planning a Cure for HIV.
    Nema V, Singh HO
    BAOJ HIV 2017; 3: 022.
  • Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND
    Singh H, Marathe SD, Nain S, Samani D, Nema V, Ghate MV, Gangakhedkar RR.
    J Biosciences. 2017 Sept; 42(3): 481-490.
  • Characterization of vaginal lactobacilli from HIV-negative and HIV-positive Indian women and their association with genital HIV-1 shedding
    Mane A, Angadi M, Vidhate P, Bembalkar S, Khan I, Bichare S, Ghate M, Thakar M.
    J Med Microbiol. 2017 Oct;66(10):1471-1475.
  • HECT Domain and RCC1-Like Domain-Containing Protein 5 (HERC-5) Gene Polymorphisms in HIV-1-Infected Individuals: A Study from India.
    Shaikh N, Saxena V, Pandey S, Patil A, Thakar M.
    AIDS Res Hum Retroviruses. 2017 Nov;33(11):1171-1174.
  • HIV drug resistance following a decade of the free antiretroviral therapy programme in India: A review
    Karade S, Chaturbhuj DN, Sen S, Joshi RK, Kulkarni SS, Shankar S, Gangakhedkar RR
    Int J Infect Dis. 2017 Nov 8;66:33-41.
  • Reduced Activation of CD4+ Regulatory T Cells is Associated With Preserved HIV- Specific CD8+ T Cells in Cohort of Indian Long Term Non Progressors (LTNPs)
    Singh D, Patankar J, Bichare S, Ghate M, Thakar M.
    J Hum Virol Retrovirol 2017 Dec, 5(7): 00185.
  • In Silico Prioritization, Synthesis and In Vitro Evaluation of Tembamide Analogs for Anti-HIV Activity.
    Gupta S, Kumar S, Jariwala N, Bhadane D, Bhutani KK, Kulkarni S, Singh IP
    Letters in Drug Design & Discovery 2017 Dec; 14 (12): 1455-1464.
  • Ending AIDS: The 90–90–90 strategy.
    Gangakhedkar RR.
    Armed Forces Med J India 2017; 73(1):3-4.
  • HIV par niyantran-Ek sajha prayas
    Nema V.
    ICMR Patrika. Dec 2017
  • Evaluation of the Quality Indicators in Laboratories at National AIDS Research Institute, Pune, India.
    Kulkarni S, Kale S, Ghodke U, Risbud A, Kulkarni S.
    Natl J Comm Med. 2017; 8(2): 47-51.